Stock Analiz

CVRx, Inc. CVRX

Medical/Dental Instruments · IPO 2021 · data as of November 13, 2026

$0.61Market cap $17M
Open the interactive analysis →

CVRx, Inc. (CVRX) is a healthcare company listed in the US with a market value of about $17M. In the twelve months to September 30, 2026 it had revenue of $60M and net income of -$53M, a net margin of -88.3%.

Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 56% a year, a 5-year average ROIC of -34%.

About CVRx

CVRx is listed in the US and classified in medical/dental instruments, IPO year 2021. Revenue went from $6M in 2020 to $57M in 2025, growth of about 56.4% a year. It was profitable in 0 of the last 6 years in our data. Its share count rose by 27% over three years (dilution for shareholders). It spends 20% of revenue on research and development.

Score: 1.0 / 5

Value0/5
Future growth4/5
Track record1/5
Financial health0/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year average ROIC above 12%

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.3
P/B1.3
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-243.0%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)10.4%
Revenue growth (5 yrs, per year)56.4%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-166.1%
ROIC (5-yr avg.)-34.0%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 6 years

Fiscal yearTTM202520242023202220212020
Revenue$60M$57M$51M$39M$22M$13M$6M
Net income-$53M-$53M-$60M-$41M-$41M-$43M-$14M
Free cash flow-$42M-$41M-$41M-$40M-$43M-$29M-$16M
EPS (diluted)$-2.00$-2.04$-2.65$-1.99$-2.02$-4.16$-37.01
Net margin-88.3%-94.1%-116.9%-104.8%-184.4%-330.4%-233.1%
ROIC—-56.7%-38.5%-31.7%-28.9%-14.1%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does CVRx pay a dividend?

Not currently.

Is CVRx a good stock to buy?

We do not give buy or sell advice. CVRx scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.